RNS de-risked2 Sep 2020 12:52
Although it was nasty to raise cash at the deep discount and without giving option to us participating but over all it's de-risked IMM SP. I have added more, short term it may go down close to 11p but as soon as one positive RNS lands it will fly like SNG! Below statements summarise everything,
"In response to strong investor demand, this successful and over-subscribed fundraising has brought together new and returning institutional investors, with existing and new private investors. With a strong balance sheet, a diverse and exciting therapeutic pipeline and our lead drug candidate, Lupuzor™ moving forward into an international Phase III trial, ImmuPharma is in an extremely robust position. With value enhancing news-flow over the next period, we are confident of creating long term shareholder value for all of our shareholders"